The evolving role of radiation therapy in hepatocellular carcinoma

Cancer/Radiotherapie

Volumn 12, Issue 2, 2008, Pages 96-101

  Dawson, L A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Conformal radiotherapy; Hepatocellular carcinoma; Radiation induced liver disease (RILD); Stereotactic radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; HEAVY ION RADIATION; HUMAN; LIVER CELL CARCINOMA; PATIENT SAFETY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; SHORT SURVEY; STEREOTACTIC PROCEDURE; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 41449111024     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2007.12.007     Document Type: Short Survey

References (48)

1. Abou-Alfa G.K., Schwartz L., Ricci S., Amadori D., Santoro A., Figer A., et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24 (2006) 4293-4300
2. Anscher M.S., Crocker I.R., and Jirtle R.L. Transforming growth factor-bêta 1 expression in irradiated liver. Radiat Res 122 (1990) 77-85
3. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2 (1981) 1129-1133
4. Ben-Josef E., Normolle D., Ensminger W.D., Walker S., Tatro D., Ten Haken R.K., et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23 (2005) 8739-8747
5. Blomgren H., Lax I., et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1 (1998) 63-74
6. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first 31 patients. Acta Oncol (1995) 861-870
7. Bush D.A., Hillebrand D.J., Slater J.M., and Slater J.D. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterol 127 (2004) S189-S193
8. Cheng J.C., Chuang V.P., Cheng S.H., Huang A.T., Lin Y.M., Cheng T.I., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 435-442
9. Cheng J.C., Wu J.K., Lee P.C., Liu H.S., Jian J.J., Lin Y.M., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60 (2004) 1502-1509
10. Chiba T., Tokuuye K., Matsuzaki Y., Sugahara S., Chuganji Y., Kagei K., et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 11 (2005) 3799-3805
11. Choi T.K., Edward C.S., Fan S.T., Francis P.T., and Wong J. Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology 37 (1990) 172-175
12. Dawson L.A., McGinn C.J., Normolle D., Ten Haken R.K., Walker S., Ensminger W., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
13. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., and Ten Haken R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
14. Eccles C., Brock K.K., Bissonnette J.P., Hawkins M., and Dawson L.A. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 751-759
15. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
16. Fattovich G., Giustina G., Schalm S.W., Hadziyannis S., Sanchez-Tapias J., Almasio P., et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP study group on hepatitis B virus and cirrhosis. Hepatology 21 (1995) 77-82
17. Guha C., Sharma A., Gupta S., Alfieri A., Gorla G.R., Gagandeep S., et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59 (1999) 5871-5874
18. Guo W.J., Yu E.X., Liu L.M., Li J., Chen Z., Lin J.H., et al. Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 9 (2003) 1697-1701
19. Hata M., Tokuuye K., Sugahara S., Fukumitsu N., Hashimoto T., Ohnishi K., et al. Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 107 (2006) 591-598
20. Hata M., Tokuuye K., Sugahara S., Kagei K., Igaki H., Hashimoto T., et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104 (2005) 794-801
21. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001:164-70.
22. Ingold J., Reed G., and Kaplan H. Radiation hepatitis. Am J Roentgenol 93 (1965) 200-208
23. Ishikura S., Ogino T., Furuse J., Satake M., Baba S., Kawashima M., et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 25 (2002) 189-193
24. Kato H., Tsujii H., Miyamoto T., Mizoe J.E., Kamada T., Tsuji H., et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59 (2004) 1468-1476
25. Kim T.H., Kim D.Y., Park J.W., Kim Y.I., Kim S.H., Park H.S., et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 29 (2006) 568-575
26. Kuvshinoff B.W., and Ota D.M. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132 (2002) 605-611 discussion 11-2
27. Lawrence T.S., Robertson J.M., Anscher M.S., Jirtle R.L., Ensminger W.D., and Fajardo L.F. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
28. Lax I., Blomgren H., Naslund I., and Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 (1994) 677-683
29. Lin C.S., Jen Y.M., Chiu S.Y., Hwang J.M., Chao H.L., Lin H.Y., et al. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy. Jpn J Clin Oncol 36 (2006) 212-217
30. Liu M.T., Li S.H., Chu T.C., Hsieh C.Y., Wang A.Y., Chang T.H., et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34 (2004) 532-539
31. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
32. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
33. Mendez Romero A., Wunderink W., Hussain S.M., De Pooter J.A., Heijmen B.J., Nowak P.C., et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 45 (2006) 831-837
34. Mornex F., Girarda N., Beziat C., Kubas A., Khodri M., Trepo C., et al. Feasibility and efficacy of high-dose three-dimensional radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 66 (2006) 1152-1158
35. Park H.C., Seong J., Han K.H., Chon C.Y., Moon Y.M., and Suh C.O. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
36. Park W., Lim do H., Paik S.W., Koh K.C., Choi M.S., Park C.K., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
37. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
38. Seong J., Park H.C., Han K.H., and Chon C.Y. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55 (2003) 329-336
39. Seong J., Shim S.J., Lee I.J., Han K.H., Chon C.Y., and Ahn S.H. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1037-1042
40. Tokuuye K YA, Hashimoto T, Igaki H, Hata M, Kagei K, Sugahara S, et al. Proton beam therapy alone for hepatocellular carcinoma. Gastrointestinal Cancer Symposium, 2005.
41. Tse RV, Kim JJ, Hawkins M, Lockwood G, Cummings B et al. Phase I Study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangenic sarcoma. J Clin Oncol 2008 Jan 2.
42. Wu D.H., Liu L., and Chen L.H. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 10 (2004) 2184-2189
43. Wulf J., Guckenberger M., Haedinger U., Oppitz U., Mueller G., Baier K., et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45 (2006) 838-847
44. Yamada K., Izaki K., Sugimoto K., Mayahara H., Morita Y., Yoden E., et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57 (2003) 113-119
45. Yamada K., Soejima T., Sugimoto K., Mayahara H., Izaki K., Sasaki R., et al. Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Jpn J Clin Oncol 31 (2001) 147-152
46. Yamasaki S.A., Marn C.S., Francis I.R., Robertson J.M., and Lawrence T.S. High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol 165 (1995) 79-84
47. Zeng Z.C., Fan J., Tang Z.Y., Zhou J., Qin L.X., Wang J.H., et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys 61 (2005) 432-443
48. Zeng Z.C., Tang Z.Y., Fan J., Zhou J., Qin L.X., Ye S.L., et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J 10 (2004) 307-316